Skip to main content

Table 2 Assessment of demographical and virological predictors for symptom severity in HMPV-infected patients

From: The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults

Characteristics

TSSS

(mean ± SD)

p

β

p*

HMPV genotype

 A, n = 40

11.53 ± 4.44

0.194a

1.329

0.194

 B, n = 41

12.85 ± 4.67

 

ref.

 

HMPV sub-lineage

 A2b, n = 25

11.16 ± 4.12

0.306b

ref.

 

 Unique A2 sub-lineage, n = 15

12.13 ± 5.03

 

0.973

0.515

 B1, n = 25

13.56 ± 4.42

 

2.400

0.067

 B2, n = 16

11.75 ± 4.99

 

0.590

0.687

Estimated no. of days elapsed between symptom onset and enrollment date

r = 0.106

0.348c

0.153

0.348

  ≤ 1–2 days, n = 20

10.95 ± 4.77

0.373b

− 1.578

0.221

 3–5 days, n = 36

12.53 ± 4.35

 

ref.

 

  ≥ 6 days, n = 25

12.72 ± 4.75

 

0.192

0.872

Sex

 Male, n = 29

12.41 ± 4.73

0.753a

− 0.337

0.753

 Female, n = 52

12.08 ± 4.54

 

ref.

 

Age

r = −0.335

0.002 c

− 0.080

0.002

  < 65 years old, n = 65

12.86 ± 4.55

0.008 a

ref.

 

  ≥ 65 years old, n = 16

9.50 ± 3.71

 

−3.362

0.008

Ethnicity

 Chinese, n = 19

10.11 ± 4.31

0.054b

− 2.763

0.030#

 Malay, n = 38

12.87 ± 4.02

 

ref.

 

 Indian, n = 21

13.33 ± 5.25

 

0.465

0.701

 Others, n = 3

9.00 ± 4.36

 

− 3.868

0.151

Viral Load (log10 RNA copies/μl), n = 78

r = −0.118

0.303c

− 0.206

0.584

  1. TSSS: Total symptom severity score, n: number of patients, SD: standard deviation, ref. category with the highest number of patients is chosen as reference
  2. aP-value calculated by Independent Samples t-Test
  3. bP-value calculated by One-way ANOVA
  4. cP-value calculated by bivariate correlations
  5. p*: p-value calculated by simple linear regression
  6. r: Pearson’s correlation coefficient
  7. β: linear regression coefficient
  8. statistically significant comparisons (p < 0.05) are in bold
  9. #p-value for significance was adjusted by Bonferroni correction to p < 0.0083 (0.05/6)